Kiernan T. DeAngelis
Direttore Tecnico/Scientifico/R&S presso Humacyte Global, Inc.
Profilo
Kiernan T.
DeAngelis is currently the Chief Medical Officer at Humacyte Global, Inc. Prior to this, he served as the Global Medical Director at AstraZeneca PLC from 2017 to 2019 and as the Senior Medical Director at United Therapeutics Corp.
from 2013 to 2017.
He also previously held the position of Chief Medical Officer at Humacyte, Inc. from 2020 to 2021.
Dr. DeAngelis completed his undergraduate degree at North Carolina State University and obtained his doctorate from Brody School of Medicine.
Posizioni attive di Kiernan T. DeAngelis
| Società | Posizione | Inizio |
|---|---|---|
Humacyte Global, Inc.
 Humacyte Global, Inc. Medical SpecialtiesHealth Technology Humacyte Global, Inc. engages in the manufacture of human acellular matrix products for vascular and non-vascular applications. It offers its products to the cardiovascular, cosmetic, soft tissue reconstruction, neurosurgical, and orthopedic markets. The company was founded by Laura E. Niklason, Juliana L. Blum and Shannon L. M. Dahl in 2004 and is headquartered in Durham, NC. | Direttore Tecnico/Scientifico/R&S | 01/04/2020 |
Precedenti posizioni note di Kiernan T. DeAngelis
| Società | Posizione | Fine |
|---|---|---|
| HUMACYTE, INC. | Direttore Tecnico/Scientifico/R&S | 01/10/2021 |
| ASTRAZENECA PLC | Direttore Tecnico/Scientifico/R&S | 01/09/2019 |
| UNITED THERAPEUTICS CORPORATION | Direttore Tecnico/Scientifico/R&S | 01/05/2017 |
Formazione di Kiernan T. DeAngelis
| Brody School of Medicine | Doctorate Degree |
| North Carolina State University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| HUMACYTE, INC. | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| UNITED THERAPEUTICS CORPORATION | Health Technology |
| Aziende private | 1 |
|---|---|
Humacyte Global, Inc.
Humacyte Global, Inc. Medical SpecialtiesHealth Technology Humacyte Global, Inc. engages in the manufacture of human acellular matrix products for vascular and non-vascular applications. It offers its products to the cardiovascular, cosmetic, soft tissue reconstruction, neurosurgical, and orthopedic markets. The company was founded by Laura E. Niklason, Juliana L. Blum and Shannon L. M. Dahl in 2004 and is headquartered in Durham, NC. | Health Technology |
- Borsa valori
- Insiders
- Kiernan T. DeAngelis
